Clinical trials
Terminated Phase 1/2 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 6 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alaunos Therapeutics | 1 |
| Amgen | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| BioNTech SE | 1 |
| Genoscience Pharma | 1 |
| Incyte Corporation | 1 |
| TCR2 Therapeutics | 1 |
| Tango Therapeutics, Inc. | 1 |
| TriSalus Life Sciences, Inc. | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 12 |
| Biliary Tract Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Gallbladder Neoplasms | 2 |
| Mesothelioma | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.